易方达中证万得生物科技指数(LOF)C(010572)利润分配表
| |
2024-12-31 |
2024-06-30 |
2023-12-31 |
2023-06-30 |
| 收入 |
-187,240,579.12 |
-245,309,460.58 |
-117,505,024.92 |
-157,872,009.55 |
| 利息合计 |
1,324,269.23 |
1,155,160.32 |
3,637,190.85 |
1,815,455.56 |
| 其中：存款利息收入 |
134,911.66 |
81,840.15 |
188,241.34 |
101,802.65 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益合计 |
-79,024,209.36 |
-25,030,708.02 |
-76,847,833.71 |
-32,051,736.57 |
| 其中：股票投资收益 |
-89,266,010.25 |
-32,711,696.68 |
-87,205,462.86 |
-41,234,761.95 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
381,514.73 |
268,063.91 |
51,422.98 |
- |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
9,860,286.16 |
7,412,924.75 |
10,306,206.17 |
9,183,025.38 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
-109,866,693.10 |
-221,493,053.15 |
-44,634,618.19 |
-127,903,688.66 |
| 其他收入 |
326,054.11 |
59,140.27 |
340,236.13 |
267,960.12 |
| 费用 |
5,011,337.28 |
2,576,202.92 |
6,469,395.98 |
3,333,216.02 |
| 管理人报酬 |
3,642,845.48 |
1,871,519.26 |
4,796,131.05 |
2,481,309.86 |
| 基金托管费 |
728,569.07 |
374,303.85 |
959,226.21 |
496,261.93 |
| 销售服务费 |
244,776.15 |
117,107.94 |
278,573.54 |
136,294.58 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中：卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
390,864.54 |
209,407.56 |
423,046.81 |
213,179.19 |
| 利润总额 |
-192,251,916.40 |
-247,885,663.50 |
-123,974,420.90 |
-161,205,225.57 |
微信公众号
证券之星APP
基本资料
